

The ER/PR Assay (Breast Cancer) detects estrogen and progesterone receptors in breast tumors to help guide treatment, assess prognosis, and predict response to hormone therapy. Patients with ER-positive and/or PR-positive tumors are more likely to benefit from treatments such as Tamoxifen.
Other Name: Estrogen Receptor Assay (ER), Progesterone Receptor Assay (PR)
No patient preparation is required for this service
4th Floor, Sterling Centre, 131 Dela Rosa cor. Ormaza St., Legaspi Village, Makati City
Add more services to your booking and save on multiple visits






